OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy
Hans H. Stassen, Silke Bachmann, René Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience (2020) Vol. 271, Iss. 3, pp. 507-520
Open Access | Times Cited: 13

Showing 13 citing articles:

Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
Hans H. Stassen, Silke Bachmann, René Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 4, pp. 603-619
Open Access | Times Cited: 31

Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, Vicent Balanzá‐Martínez, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100962-100962
Open Access

Fecal Metabolomics and Network Pharmacology Reveal the Correlations between Constipation and Depression
Xiaojie Liu, Huanle Liu, Fuxiao Wei, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 10, pp. 4771-4786
Closed Access | Times Cited: 18

Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting
Madeline B. Benz, Gary Epstein‐Lubow, Lauren M. Weinstock, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 273-277
Open Access | Times Cited: 7

Machine Learning as a Tool to Find New Pharmacological Targets in Mood Disorders: A Systematic Review
Joana Romão, António Melo, Rita André, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 3, pp. 241-264
Open Access | Times Cited: 2

How Shared Is Shared Decision Making? Reaching the Full Potential of Patient-Clinician Collaboration in Mental Health
Emily B. H. Treichler, Borsika A. Rabin, Amy N. Cohen, et al.
Harvard Review of Psychiatry (2021) Vol. 29, Iss. 5, pp. 361-369
Closed Access | Times Cited: 11

Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia
Ena Španić Popovački, Dora Vogrinc, Heidi R. Fuller, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 302-302
Open Access | Times Cited: 1

Means to an end: Characteristics and follow‐up of emergency department patients with a history of suicide attempt via medication overdose
Madeline B. Benz, Neil S. Rafferty, Sarah A. Arias, et al.
Academic Emergency Medicine (2024) Vol. 32, Iss. 2, pp. 147-157
Closed Access

Genetic determinants of antidepressant and antipsychotic drug response
Hans H. Stassen, Silke Bachmann, René Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access

Monitoring the effects of therapeutic interventions in depression through self-assessments
Inés Moragrega, René Bridler, Christine Möhr, et al.
Research in Psychotherapy Psychopathology Process and Outcome (2021) Vol. 24, Iss. 3
Open Access

Page 1

Scroll to top